Delivery Order SPE2DB24D8002-SPE2DB25FJNAG

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,163.00, is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, which is part of the DLA Troop...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a Delivery Order valued at $3,462.21 with a Firm Fixed Price pricing type. The ultimate completion date is June 24, 2025. The contract was awarded by the Defense Logistics Agency (DLA), which is a defense agency, for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S. This contract is associated with a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, with an ID of SPE2DX15D8002|SPE2DX24F2WP4, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a delivery order valued at $2,054.23 for the supply of 4564804060 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The contract is not set aside and is a firm fixed price arrangement. Dakota Drug, Inc. has been awarded an Indefinite Delivery...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,511.06 firm-fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET in support of U.S. Armed Forces medical operations. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) that allows the company to provide a comprehensive range of pharmaceutical products,...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the procurement of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a ceiling value of $1,550.66 and a period of performance through December 16, 2024. It is a firm fixed-price contract, with no set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $7,921.62 and a period of performance through May 3, 2024. It is a firm fixed-price contract for the delivery of pharmaceutical products and medical supplies, including varenicline starting month boxes, to support U.S. Armed Forces medical operations. Dakota Drug, Inc....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $4,126.76. It is a firm fixed price contract for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract does not have a...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNAG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, with a ceiling value of $4,828.23 and a completion date of January 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, and this award is part of the company's larger Indefinite Delivery Contract (IDC) with the DLA's Troop Support Medical division, which has a potential value of $999,999,999.00 and extends through December 31, 2025. This contract supports the DLA's ECAT Generation V Program, providing critical medical supplies and equipment to various defense healthcare facilities.

Generated 5/21/25, 10:36 AM